# Novartis Pharmaceuticals Corporation – FDA Untitled Letter, Aug 8, 2023

Source: https://www.keypedia.com/records/untitled_letter/novartis-pharmaceuticals-corporation/cd26624a-3912-48a5-979f-444b80110332

> FDA UNTITLED_LETTER for Novartis Pharmaceuticals Corporation on August 08, 2023. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2023-08-08

## Related Documents

- [483 - 2026-02-06](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/5f685210-dc63-45e1-8c77-efd089d4eafb) — date: February 6, 2026
- [483 - 2024-08-08](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/44e0cb23-0ec8-4334-bb8c-6f66a38965a7) — date: August 8, 2024
- [483 - 2022-12-09](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/b1680319-d6ed-404f-97d8-29d30a5966c6) — date: December 9, 2022
- [483 - 2019-08-21](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/46e237ea-aa74-4167-91ef-3f93ae6e17f4) — date: August 21, 2019
- [EIR - 2019-08-21](https://www.keypedia.com/records/eir/novartis-pharmaceuticals-corporation/43fb0c26-6023-4fdb-a1bf-b32b89a06cda) — date: August 21, 2019

## Related Officers

- [Director of Compliance Branch](https://www.keypedia.com/people/alexander-lopez/0226b709-12ab-42a4-b63b-c7e8ce64ea02)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47